Filing Details
- Accession Number:
- 0001214659-25-011356
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-01 16:30:19
- Reporting Period:
- 2025-07-30
- Filing Date:
- 2025-08-01
- Accepted Time:
- 2025-08-01 16:30:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1677077 | Alzamend Neuro Inc. | ALZN | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1212502 | Iii C Milton Ault | 11411 Southern Highlands Parkway Suite 190 Las Vegas NV 89141 | No | No | No | No |
Transaction Summary
| Sold: | 129,449 shares | Avg. Price: $2.28 | Total Value: $295,531.78 |
| Number of Shares After Transactions: | 8,260 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-07-30 | 100,000 | $2.32 | 137,709 | No | 4 | C | Indirect | By Ault Lending, LLC |
| Common Stock | Disposition | 2025-07-30 | 29,449 | $2.51 | 108,260 | No | 4 | S | Indirect | By Ault Lending, LLC |
| Common Stock | Disposition | 2025-07-31 | 100,000 | $2.22 | 8,260 | No | 4 | S | Indirect | By Ault Lending, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Ault Lending, LLC |
| No | 4 | S | Indirect | By Ault Lending, LLC |
| No | 4 | S | Indirect | By Ault Lending, LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2025-07-30 | 232 | $1,000.00 | 100,000 | $2.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,535 | 2024-01-31 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,843 | Direct | |
| Common Stock | 11,068 | Indirect | By Ault Life Sciences, Inc. |
| Common Stock | 61 | Indirect | By Ault Life Sciences Fund, LLC |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Purchase Warrants | $108.00 | 2024-08-01 | 2029-08-01 | 13,556 | 13,556 | Indirect |
| Common Stock | Common Stock Purchase Warrants | $108.00 | 2024-09-27 | 2029-09-27 | 8,667 | 8,667 | Indirect |
| Common Stock | Common Stock Purchase Warrants | $108.00 | 2024-10-30 | 2029-10-30 | 1,111 | 1,111 | Indirect |
| Common Stock | Common Stock Purchase Warrants | $4,050.00 | 2020-08-31 | 2025-08-31 | 12 | 12 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2029-08-01 | 13,556 | 13,556 | Indirect |
| 2029-09-27 | 8,667 | 8,667 | Indirect |
| 2029-10-30 | 1,111 | 1,111 | Indirect |
| 2025-08-31 | 12 | 12 | Indirect |
Footnotes
- Represents shares of common stock received upon conversion of Series B convertible preferred stock ("Series B Preferred").
- Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
- The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.5122. The range of sales prices on the transaction date was $2.4047 to $2.6367 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.2155. The range of sales prices on the transaction date was $2.1628 to $2.2511 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
- Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
- The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain of Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock.
- The shares of Series B Preferred have no expiration date.
- Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by HSD.
Billionaire Hedge Funds
